HGH Biosimilars Market Report

Global and Region HGH Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：179
  • REPORT CODE：GMM976768
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.

    The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and OthersCompany profiles are primarily based on public domain information including companyJohnson & JohnsonPaciraCSPCKingond PharmLuye PharmaTeva PharmaceuticalJohnson & JohnsonSun PharmaceuticalGilead SciencesSigma-Tau GroupFudan-Zhangjiang

    The report details the trend, potential and market size of HGH Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of HGH Biosimilarsmarket, defines the market attractiveness level of HGH Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of HGH Biosimilars industry, describes the types of HGH Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global HGH Biosimilars market and the development prospects and opportunities of HGH Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HGH Biosimilars market in Chapter 13.

    By Player:

    • Novartis

    • Pacira

    • CSPC

    • Kingond Pharm

    • Luye Pharma

    • Teva Pharmaceutical

    • Johnson & Johnson

    • Sun Pharmaceutical

    • Gilead Sciences

    • Sigma-Tau Group

    • Fudan-Zhangjiang

    By Type:

    • Clinical

    • Experiment

    By End-User:

    • Treament

    • Prevention

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 HGH Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 HGH Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 HGH Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 HGH Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise HGH Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global HGH Biosimilars Consumption (2017-2022)

    • 7.2 United States HGH Biosimilars Consumption (2017-2022)

    • 7.3 Europe HGH Biosimilars Consumption (2017-2022)

    • 7.4 China HGH Biosimilars Consumption (2017-2022)

    • 7.5 Japan HGH Biosimilars Consumption (2017-2022)

    • 7.6 India HGH Biosimilars Consumption (2017-2022)

    • 7.7 South Korea HGH Biosimilars Consumption (2017-2022)

    8 Region and Country-wise HGH Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India HGH Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea HGH Biosimilars Consumption Forecast (2022-2028)

    9 Global HGH Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global HGH Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Clinical Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Experiment Consumption and Growth Rate (2017-2022)

    • 9.2 Global HGH Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Treament Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Prevention Consumption and Growth Rate (2017-2022)

    10 Global HGH Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global HGH Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Clinical Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Experiment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global HGH Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Treament Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Prevention Consumption Forecast and Growth Rate (2022-2028)

    11 Global HGH Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global HGH Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global HGH Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 HGH Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global HGH Biosimilars Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis HGH Biosimilars Product and Service

    • 14.2 Pacira

      • 14.2.1 Pacira Company Details

      • 14.2.2 Pacira HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pacira HGH Biosimilars Product and Service

    • 14.3 CSPC

      • 14.3.1 CSPC Company Details

      • 14.3.2 CSPC HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CSPC HGH Biosimilars Product and Service

    • 14.4 Kingond Pharm

      • 14.4.1 Kingond Pharm Company Details

      • 14.4.2 Kingond Pharm HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Kingond Pharm HGH Biosimilars Product and Service

    • 14.5 Luye Pharma

      • 14.5.1 Luye Pharma Company Details

      • 14.5.2 Luye Pharma HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Luye Pharma HGH Biosimilars Product and Service

    • 14.6 Teva Pharmaceutical

      • 14.6.1 Teva Pharmaceutical Company Details

      • 14.6.2 Teva Pharmaceutical HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical HGH Biosimilars Product and Service

    • 14.7 Johnson & Johnson

      • 14.7.1 Johnson & Johnson Company Details

      • 14.7.2 Johnson & Johnson HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson HGH Biosimilars Product and Service

    • 14.8 Sun Pharmaceutical

      • 14.8.1 Sun Pharmaceutical Company Details

      • 14.8.2 Sun Pharmaceutical HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sun Pharmaceutical HGH Biosimilars Product and Service

    • 14.9 Gilead Sciences

      • 14.9.1 Gilead Sciences Company Details

      • 14.9.2 Gilead Sciences HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Gilead Sciences HGH Biosimilars Product and Service

    • 14.10 Sigma-Tau Group

      • 14.10.1 Sigma-Tau Group Company Details

      • 14.10.2 Sigma-Tau Group HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sigma-Tau Group HGH Biosimilars Product and Service

    • 14.11 Fudan-Zhangjiang

      • 14.11.1 Fudan-Zhangjiang Company Details

      • 14.11.2 Fudan-Zhangjiang HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Fudan-Zhangjiang HGH Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of HGH Biosimilars

    • Figure HGH Biosimilars Picture

    • Table Global HGH Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HGH Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HGH Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global HGH Biosimilars Consumption by Country (2017-2022)

    • Figure United States HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea HGH Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global HGH Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea HGH Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Consumption and Growth Rate (2017-2022)

    • Figure Global Experiment Consumption and Growth Rate (2017-2022)

    • Figure Global Treament Consumption and Growth Rate (2017-2022)

    • Figure Global Prevention Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Experiment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treament Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Table Global HGH Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global HGH Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis HGH Biosimilars Product and Service

    • Table Pacira (Foundation Year, Company Profile and etc.)

    • Table Pacira HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacira HGH Biosimilars Product and Service

    • Table CSPC (Foundation Year, Company Profile and etc.)

    • Table CSPC HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC HGH Biosimilars Product and Service

    • Table Kingond Pharm (Foundation Year, Company Profile and etc.)

    • Table Kingond Pharm HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kingond Pharm HGH Biosimilars Product and Service

    • Table Luye Pharma (Foundation Year, Company Profile and etc.)

    • Table Luye Pharma HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luye Pharma HGH Biosimilars Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical HGH Biosimilars Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson HGH Biosimilars Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical HGH Biosimilars Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences HGH Biosimilars Product and Service

    • Table Sigma-Tau Group (Foundation Year, Company Profile and etc.)

    • Table Sigma-Tau Group HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Tau Group HGH Biosimilars Product and Service

    • Table Fudan-Zhangjiang (Foundation Year, Company Profile and etc.)

    • Table Fudan-Zhangjiang HGH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fudan-Zhangjiang HGH Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US